Cargando…

Circulating cell death products predict clinical outcome of colorectal cancer patients

BACKGROUND: Tumor cell death generates products that can be measured in the circulation of cancer patients. CK18-Asp396 (M30 antigen) is a caspase-degraded product of cytokeratin 18 (CK18), produced by apoptotic epithelial cells, and is elevated in breast and lung cancer patients. METHODS: We determ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koelink, Pim J, Lamers, Cornelis BHW, Hommes, Daan W, Verspaget, Hein W
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666761/ https://www.ncbi.nlm.nih.gov/pubmed/19302716 http://dx.doi.org/10.1186/1471-2407-9-88

Ejemplares similares

Clinical significance of stromal apoptosis in colorectal cancer
por: Koelink, P J, et al.
Publicado: (2009)

MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not
por: Langers, A M J, et al.
Publicado: (2008)

MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients
por: Langers, A M J, et al.
Publicado: (2012)

The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer
por: Kodach, Liudmila L., et al.
Publicado: (2010)

Immunomodulatory Effects of Mesenchymal Stromal Cells in Crohn's Disease
por: Molendijk, Ilse, et al.
Publicado: (2012)

Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas.
por: Tang, C., et al.
Publicado: (1997)

Superoxide dismutases in relation to the overall survival of colorectal cancer patients.
por: Janssen, A. M., et al.
Publicado: (1998)

Tissue level, activation and cellular localisation of TGF-β1 and association with survival in gastric cancer patients
por: Hawinkels, L J A C, et al.
Publicado: (2007)

Collagen degradation and neutrophilic infiltration: a vicious circle in inflammatory bowel disease
por: Koelink, Pim J, et al.
Publicado: (2014)

Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.
por: Ganesh, S., et al.
Publicado: (1997)

Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer
por: Brocco, Davide, et al.
Publicado: (2022)

Diminished Expression of Corticotropin-Releasing Hormone Receptor 2 in Human Colon Cancer Promotes Tumor Growth and Epithelial-to-Mesenchymal Transition via Persistent Interleukin-6/Stat3 Signaling
por: Rodriguez, Jorge A., et al.
Publicado: (2015)

CD276-Positive Circulating Endothelial Cells Do Not Predict Response to Systemic Therapy in Advanced Colorectal Cancer
por: Gootjes, Elske C., et al.
Publicado: (2020)

Plasminogen activators in endoscopic biopsies as indicators of gastrointestinal cancer: comparison with resection specimens.
por: de Bruin, P. A., et al.
Publicado: (1989)

Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer
por: Andersen, C L, et al.
Publicado: (2009)

Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis.
por: Sier, C. F., et al.
Publicado: (1995)

Circulating Levels of Osteopontin Predict Patients’ Outcome after Resection of Colorectal Liver Metastases
por: Loosen, Sven H., et al.
Publicado: (2018)

Assessing Clinical Outcomes in Colorectal Cancer with Assays for Invasive Circulating Tumor Cells
por: Zhang, Yue, et al.
Publicado: (2018)

Clinical significance of circulating tumor cells in predicating the outcomes of patients with colorectal cancer
por: Chen, Kehe, et al.
Publicado: (2022)

Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer()
por: Huang, Ming-Yii, et al.
Publicado: (2016)

Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II–III colorectal cancer patients
por: Sun, Fan, et al.
Publicado: (2018)

Toll-like receptor 6 stimulation promotes T-helper 1 and 17 responses in gastrointestinal-associated lymphoid tissue and modulates murine experimental colitis
por: Morgan, M E, et al.
Publicado: (2014)

New circulating biomarkers for predicting cardiovascular death in healthy population
por: Melander, Olle, et al.
Publicado: (2015)

Circulating Tumour DNA as Biomarker for Colorectal Liver Metastases: A Systematic Review and Meta-Analysis
por: Wullaert, Lissa, et al.
Publicado: (2023)

Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
por: Nijmeijer, Rian M., et al.
Publicado: (2011)

Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer
por: Ligthart, Sjoerd T., et al.
Publicado: (2013)

Monocyte TREM-1 Levels Associate With Anti-TNF Responsiveness in IBD Through Autophagy and Fcγ-Receptor Signaling Pathways
por: Prins, Marileen M., et al.
Publicado: (2021)

Circulating endothelial cells in oncology: pitfalls and promises
por: Strijbos, M H, et al.
Publicado: (2008)

Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study
por: Bork, U, et al.
Publicado: (2015)

Circulating Biomarkers of Cell Adhesion Predict Clinical Outcome in Patients with Chronic Heart Failure
por: Bouwens, Elke, et al.
Publicado: (2020)

Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease?
por: Kruidenier, L, et al.
Publicado: (1998)

Prediction of colorectal cancer diagnosis based on circulating plasma proteins
por: Surinova, Silvia, et al.
Publicado: (2015)

Systemic inflammation is associated with circulating cell death released keratin 18 fragments in colorectal cancer
por: Sirniö, Päivi, et al.
Publicado: (2020)

Circulating CXCL10 and IL-6 in solid organ donors after brain death predict graft outcomes
por: Piemonti, Lorenzo, et al.
Publicado: (2021)

Clinical utility of circulating tumor DNA for colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2019)

FoxP3- and CD8-positive Infiltrating Immune Cells Together Determine Clinical Outcome in Colorectal Cancer
por: Zeestraten, Eliane C. M., et al.
Publicado: (2011)

Circulating immune checkpoints predict heart failure outcomes
por: Screever, Elles M., et al.
Publicado: (2023)

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer
por: Kubben, F J G M, et al.
Publicado: (2006)

Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management
por: Hallermayr, Ariane, et al.
Publicado: (2022)

Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
por: Hao, T B, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_15lluplpafss4d7cdthq4cn6ma